In breast cancer tissues, the total immunostaining score of PLOD1 expression was significantly associated with the ER status (P = 0.04384), the TNBC status (P = 0.01592) and tumor grade (P = 0.001192). This evidence concerns the gene PLOD1 and breast carcinoma.